Clinical markers of long-term disability in RRMS patients treated with interferon beta

被引：0
|
作者：
Rio, J. [1 ]
Otero-Romero, S. [1 ,2 ]
Tintore, M. [1 ]
Comabella, M. [1 ]
Nos, C. [1 ]
Negrotto, L. [1 ]
Galan, I. [1 ]
Vidal-Jordana, A. [1 ]
Castillo, J. [1 ]
Palavra, F. [1 ]
Simon, E. [1 ]
Arrambide, G. [1 ]
Sastre-Garriga, J. [1 ]
Montalban, X. [1 ]
机构：
[1] Vall Hebron Univ Hosp, Multiple Sclerosis Ctr Catalonia, Dept Neuroimmunol, Barcelona, Spain
[2] Vall Hebron Univ Hosp, Prevent Med & Epidemiol Dept, Barcelona, Spain
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P285
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [31] Long-term outcome improvement in patients with chronic hepatitis D treated with interferon α
    Vlad Ratziu
    Thierry Poynard
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 : 76 - 77
  • [32] Long-term clinical outcomes of STEMI patients treated with BVS
    Felix, C. M.
    Fam, J. M.
    Ishibashi, Y.
    Diletti, R.
    Onuma, Y.
    Everaert, B.
    Regar, E.
    Van Mieghem, N. M. D. A.
    Zijlstra, F.
    Van Geuns, R. J. M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 510 - 510
  • [33] Long-Term Treatment with Interferon Beta - a Case Report
    Valis, M.
    Kunc, P.
    Ryska, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 : 22 - 24
  • [34] Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate
    Healy, Brian C.
    Glanz, Bonnie I.
    Zurawski, Jonathan D.
    Mazzola, Maria
    Chitnis, Tanuja
    Weiner, Howard L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 394 : 127 - 131
  • [35] Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis
    Tomassini, V
    Paolillo, A
    Russo, P
    Giugni, E
    Prosperini, L
    Gasperini, C
    Antonelli, G
    Bastianello, S
    Pozzilli, C
    JOURNAL OF NEUROLOGY, 2006, 253 (03) : 287 - 293
  • [36] Long-term efficacy of ocrelizumab in RRMS patients after natalizumab discontinuation
    Mancinelli, Chiara Rosa
    Scarpazza, Cristina
    Cordioli, Cinzia
    De Rossi, Nicola
    Rasia, Sarah
    Capra, Ruggero
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 989 - 989
  • [37] Long-Term Disease Control with Fingolimod in RRMS Patients With Active Disease
    Havrdova, Eva Kubala
    Silva, Diego
    Kappos, Ludwig
    Meinert, Rolf
    Cohen, Jeffrey
    Devonshire, Virginia
    NEUROLOGY, 2018, 90
  • [38] Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network
    Iaffaldano, Pietro
    Lucisano, Giuseppe
    Butzkueven, Helmut
    Hillert, Jan
    Hyde, Robert
    Koch-Henriksen, Nils
    Magyari, Melinda
    Pellegrini, Fabio
    Spelman, Tim
    Sorensen, Per Soelberg
    Vukusic, Sandra
    Trojano, Maria
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (10) : 1543 - 1555
  • [39] Long-term clinical outcome of patients treated with β-brachytherapy in routine clinical practice
    Nikas, Dimitrios N.
    Kalef-Ezra, John
    Katsouras, Christos S.
    Tsekeris, Periklis
    Bozios, George
    Pappas, Christos
    Naka, Katerina K.
    Kotsia, Anna
    Papamichael, Nikolaos
    Sideris, Dimitrios A.
    Michalis, Lampros K.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 115 (02) : 183 - 189
  • [40] Long term outcome of chronic hepatitis B patients treated with interferon gamma and beta.
    Kishida, Y
    Kashiwagi, T
    Suzuki, IY
    Yamada, Y
    Yoshihara, H
    Kamada, T
    Akeyama, T
    Katayama, K
    Kasahara, A
    Hayashi, N
    HEPATOLOGY, 1997, 26 (04) : 1647 - 1647
12345